Seeking Alpha
 

Medtox Scientific, Inc. (MTOX)

- NASDAQ
MTOX is defunct.
Show Summaries  |  Hide Summaries
  • Jun. 5, 2012, 1:04 PM
    MEDTOX Scientific (MTOX +0.1%) holds its own after being downgraded to Sell at Craig-Hallum. The firm says that after accepting LabCorp's bid, another offer is unlikely to emerge. The firm also notes that the closing could be delayed by regulatory scrutiny.
    | Comment!
  • Jun. 4, 2012, 9:37 AM
    LabCorp. (LH) agrees to acquire forensic and clinical laboratory Medtox Scientific (MTOX) for $241M, with the $27/share offer representing a 37% premium over the latter's closing price of $19.70 on Friday. The acquisition comes as LabCorp. expands its Toxicology Center of Excellence.
    | Comment!
  • Apr. 12, 2012, 7:12 AM
    Medtox Scientific (MTOX): Q1 EPS of $0.17 beats by $0.04. Revenue of $28.6M (+13.9% Y/Y) beats by $1.2M. (PR)
    | Comment!
  • Feb. 9, 2012, 7:22 AM
    Medtox Scientific (MTOX): Q4 EPS of $0.11 misses by $0.01. Revenue of $26.9M (+7.6% Y/Y) in-line. (PR)
    | Comment!
  • Oct. 13, 2011, 12:19 PM
    Biotech firm Medtox (MTOX -5.3%) trades lower after its Q3 missed estimates due to reduced order flow from its existing customers. EPS came in at $0.15 on sales of $27M, below analysts' expectations for an EPS of $0.17 on revenue of $28.5M.
    | Comment!
  • Jul. 16, 2008, 1:52 AM
    Notable earnings before Wednesday's open: ABT, AMB, DAL, FMBI, GCI, HST, LUFK, MI, MTOX, NTRS, PJC, SYBT, STJ, VLY, WFC.
    | Comment!
Visit Seeking Alpha's
Company Description
Currently, there's no company description for MTOX.